S&P Futures
4,147.50 +15.25 (+0.37%) Dow Futures
34,003.00 -145.00 (-0.42%) Nasdaq Futures
12,570.50 +156.25 (+1.26%) Russell 2000 Futures
1,966.20 -2.20 (-0.11%) Crude Oil
76.09 -0.32 (-0.42%) Gold
1,969.90 +27.10 (+1.39%)
Semler Scientific, Inc. (SMLR)
Pre-Market:
Chart Events
Performance Outlook
| Previous Close | 39.21 |
| Open | 39.25 |
| Bid | 29.50 x 1100 |
| Ask | 65.26 x 800 |
| Day's Range | 38.81 - 41.44 |
| 52 Week Range | 26.70 - 81.99 |
| Volume | |
| Avg. Volume | 27,729 |
| Market Cap | 280.781M |
| Beta (5Y Monthly) | 0.65 |
| PE Ratio (TTM) | 26.15 |
| EPS (TTM) | 1.57 |
| Earnings Date | Feb 27, 2023 - Mar 03, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 65.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for SMLR
Related Research
- Semler Scientific, Inc.Analyst Report: Thermo Fisher Scientific Inc.Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%).RatingFair ValueEconomic Moat20 hours agoMorningstar
- PR Newswire
Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that a study was published in the peer-reviewed AJPM Focus with data collected using the company's QuantaFlo® PAD test under real-world conditions, illustrating the benefits of PAD in-home screening. AJPM Focus is the official open access journal jointly launched this year by both The American College of Preventive Medi
- PR Newswire
Semler Announces Investment in Monarch Medical Technologies
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced an up to $5.0 million investment in privately-held Monarch Medical Technologies, LLC (Monarch) through the purchase of a senior secured convertible promissory note. Repayment of the note is secured by a first priority interest in all of Monarch's assets.
- PR Newswire
Semler Reports Third Quarter and Year-to-Date 2022 Financial Results
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and nine months ended September 30, 2022.
